Description |
Nomilin is a limonoid compound obtained from the extracts of citrus fruits. Nomilin is an anti-obesity and anti-hyperglycemic agent [1][2].
|
In Vitro |
Nomilin treatment significantly mitigated cell death and decreased lactate dehydrogenase (LDH) release and ROS production in SH-SY5Y cells induced by oxygen-glucose deprivation (OGD), which was almost abolished by Nrf2 knockdown[1].
|
In Vivo |
Nomilin attenuated blood-brain barrier (BBB) disruption in MCAO rats, which might be associated with alleviating the loss of tight junction proteins, including ZO-1 and occludin-5[1].
|
Density | 1.3±0.1 g/cm3 |
Boiling Point | 657.7±55.0 °C at 760 mmHg |
Flash Point | 351.6±31.5 °C |
Exact Mass | 514.220276 |
PSA | 121.64000 |
LogP | 2.47 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |